BetterLife Pharma (BETRF) Enterprise Value (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Enterprise Value of $2.4 million for Q2 2026, up 2.7% year-over-year from $2.3 million in Q2 2025, and up 0.63% quarter-over-quarter from $2.4 million in Q1 2026.
BetterLife Pharma (BETRF) Enterprise Value (2011 - 2026) Analysis & Trends
BetterLife Pharma's Enterprise Value history runs 16 years deep, the most recent figure standing at $2.4 million for Q2 2026.
- In Q2 2026, Enterprise Value rose 2.7% year-over-year to $2.4 million; the TTM figure through Apr 2026 stood at $2.4 million (up 2.7% YoY), while the FY2026 annual figure was $2.4 million, up 1.61% from the prior year.
- Enterprise Value for Q2 2026 stood at $2.4 million, up from $2.4 million in the prior quarter.
- The five-year high for Enterprise Value was $2.8 million in Q4 2022, with the low at -$137089.4 in Q1 2022.
- The 5-year median for Enterprise Value is $2.3 million (2025), against an average of $1.9 million.
- Peak annual rise in Enterprise Value reached 1823.26% in 2023, while the deepest fall reached 36.58% in 2023.
- BetterLife Pharma's Enterprise Value stood at $2.8 million in 2022, then slumped by 36.58% to $1.8 million in 2023, then jumped by 37.05% to $2.4 million in 2024, then fell by 1.81% to $2.4 million in 2025, then fell by 0.45% to $2.4 million in 2026.
- Business Quant data shows BETRF's Enterprise Value at $2.4 million in Q2 2026, $2.4 million in Q1 2026, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.38 Mn |
| Jan 31, 2026 | 2.37 Mn |
| Jul 31, 2025 | 2.39 Mn |
| Apr 30, 2025 | 2.32 Mn |
| Jan 31, 2025 | 2.33 Mn |
| Oct 31, 2024 | 2.44 Mn |
| Jul 31, 2024 | 2.32 Mn |
| Apr 30, 2024 | 1.92 Mn |
| Jan 31, 2024 | 2.27 Mn |
| Oct 31, 2023 | 1.78 Mn |
| Jul 31, 2023 | 1.84 Mn |
| Apr 30, 2023 | 1.74 Mn |
| Jan 31, 2023 | 2.36 Mn |
| Oct 31, 2022 | 2.80 Mn |
| Jul 31, 2022 | 412,827.25 |
| Apr 30, 2022 | 185,817.85 |
| Jan 31, 2022 | -137,089.43 |
| Oct 31, 2021 | -1.70 Mn |
| Jul 31, 2021 | -3.46 Mn |
| Apr 30, 2021 | -218,238.01 |